Vellareddy Anantharam Selected Research

acetovanillone (apocynin)

1/2021	PKC Delta Activation Promotes Endoplasmic Reticulum Stress (ERS) and NLR Family Pyrin Domain-Containing 3 (NLRP3) Inflammasome Activation Subsequent to Asynuclein-Induced Microglial Activation: Involvement of Thioredoxin-Interacting Protein (TXNIP)/Thioredoxin (Trx) Redoxisome Pathway.
1/2018	Manganese exposure induces neuroinflammation by impairing mitochondrial dynamics in astrocytes.
11/2017	Mito-Apocynin Prevents Mitochondrial Dysfunction, Microglial Activation, Oxidative Damage, and Progressive Neurodegeneration in MitoPark Transgenic Mice.
1/2017	Neuronal protection against oxidative insult by polyanhydride nanoparticle-based mitochondria-targeted antioxidant therapy.
1/2016	Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson's Disease.
10/2012	Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vellareddy Anantharam Research Topics

Disease

42	Parkinson Disease (Parkinson's Disease) 01/2022 - 03/2003
15	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 08/2005
15	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 03/2003
7	Inflammation (Inflammations) 01/2022 - 11/2009
5	Synucleinopathies 01/2021 - 01/2017
5	Scrapie 01/2020 - 09/2006
5	Neuroinflammatory Diseases 01/2019 - 04/2012
5	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2017 - 09/2006
4	Parkinsonian Disorders (Parkinsonism) 01/2021 - 07/2017
4	Nervous System Diseases (Neurological Disorders) 01/2018 - 04/2005
3	Gliosis 11/2020 - 01/2018
3	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2017
2	Infections 01/2022 - 01/2014
2	Dysbiosis 01/2022 - 01/2022
2	Status Epilepticus (Complex Partial Status Epilepticus) 11/2020 - 01/2020
2	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2020 - 07/2017
1	Clostridium Infections 01/2022
1	Endotoxemia 08/2020
1	Brain Injuries (Brain Injury) 01/2020
1	Seizures (Absence Seizure) 01/2020
1	Lewy Body Disease (Lewy Body Dementia) 01/2020
1	Pathologic Processes 01/2019
1	Dementia (Dementias) 01/2019
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2019
1	Hypoxia (Hypoxemia) 01/2018
1	Tauopathies 01/2017
1	Proteostasis Deficiencies 01/2017
1	Cardiomyopathies (Cardiomyopathy) 01/2017
1	Cognitive Dysfunction 01/2017
1	Movement Disorders (Movement Disorder) 01/2017
1	Insulin Resistance 01/2017

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2005
13	ManganeseIBA 12/2019 - 04/2005
10	Phosphotransferases (Kinase)IBA 01/2021 - 08/2005
10	SynucleinsIBA 12/2020 - 02/2011
7	Protein Kinases (Protein Kinase)IBA 01/2016 - 11/2006
6	acetovanillone (apocynin)IBA 01/2021 - 10/2012
6	PrionsIBA 01/2020 - 09/2006
5	CytokinesIBA 01/2021 - 11/2009
5	InflammasomesIBA 01/2021 - 01/2017
5	Protein Kinase C-deltaIBA 01/2021 - 08/2005
5	Biomarkers (Surrogate Marker)IBA 12/2020 - 04/2015
5	MetalsIBA 12/2019 - 06/2010
5	AntioxidantsIBA 01/2018 - 09/2006
4	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2009 - 09/2006
4	UbiquitinIBA 08/2009 - 09/2006
3	Neuroprotective AgentsIBA 01/2022 - 09/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 03/2002
3	EnzymesIBA 01/2021 - 11/2009
3	alpha-SynucleinIBA 01/2021 - 09/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2020 - 04/2012
3	Biological ProductsIBA 12/2019 - 01/2017
3	Prion ProteinsIBA 10/2011 - 09/2006
2	RotenoneIBA 01/2022 - 01/2017
2	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 09/2006
2	Isoflurophate (DFP)FDA Link 11/2020 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 11/2020 - 08/2020
2	ChemokinesIBA 11/2020 - 01/2020
2	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2018
2	Protein Kinase CIBA 01/2017 - 09/2007
2	Protein Isoforms (Isoforms)IBA 10/2011 - 09/2007
2	DieldrinIBA 10/2008 - 08/2005
2	NeurotoxinsIBA 10/2008 - 06/2007
2	Caspase 3 (Caspase-3)IBA 11/2006 - 03/2002
1	PesticidesIBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Inositol (Myoinositol)IBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	EndoribonucleasesIBA 01/2021
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2021
1	salubrinalIBA 01/2021
1	Eukaryotic Initiation Factor-2 (EIF 2)IBA 01/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	Activating Transcription Factor 4IBA 01/2021
1	InterleukinsIBA 11/2020
1	Cholinergic Agents (Cholinergics)IBA 11/2020
1	AcetylcholinesteraseIBA 11/2020
1	Blood Proteins (Serum Proteins)IBA 11/2020
1	NitritesIBA 11/2020
1	Interleukin-17 (Interleukin 17)IBA 11/2020
1	LeptinIBA 11/2020
1	Interleukin-2 (IL2)IBA 11/2020
1	src-Family KinasesIBA 08/2020
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2020
1	AntibodiesIBA 02/2020
1	3-nitrotyrosineIBA 01/2020
1	Atropine FDA LinkGeneric 01/2020
1	Diazepam (Valium)FDA LinkGeneric 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	OximesIBA 01/2020
1	ParaffinIBA 01/2020
1	Cholecystokinin (Pancreozymin)IBA 01/2019
1	QuercetinIBA 01/2017
1	Blood Glucose (Blood Sugar)IBA 01/2017
1	Amyloid (Amyloid Fibrils)IBA 01/2017
1	NAD (NADH)IBA 01/2017
1	Insulin-Like Growth Factor Binding Protein 2IBA 01/2017
1	pyridabenIBA 03/2016

Therapy/Procedure

4	Therapeutics 01/2020 - 08/2014